The stock of AstraZeneca PLC (NASDAQ:AZN) last traded at $71.28, up 1.14% from the previous session.
AZN stock price is now 1.11% away from the 50-day moving average and 3.80% away from the 200-day moving average. The market capitalization of the company currently stands at $220.52B.
A total of 0.50% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in AZN stock. A new stake in AstraZeneca PLC shares was purchased by CAPITAL RESEARCH GLOBAL INVESTORS during the first quarter worth $73,807,000. MANNING & NAPIER GROUP, LLC invested $51,676,000 in shares of AZN during the first quarter. In the first quarter, LMR PARTNERS LLP acquired a new stake in AstraZeneca PLC valued at approximately $43,825,000. CANOE FINANCIAL LP acquired a new stake in AZN for approximately $41,903,000. EXODUSPOINT CAPITAL MANAGEMENT, LP purchased a new stake in AZN valued at around $15,890,000 in the second quarter. In total, there are 1,297 active investors with 17.90% ownership of the company’s stock.
With an opening price of $70.89 on Wednesday morning, AstraZeneca PLC (NASDAQ: AZN) set off the trading day. During the past 12 months, AstraZeneca PLC has had a low of $52.65 and a high of $76.56. As of last week, the company has a debt-to-equity ratio of 0.80, a current ratio of 0.90, and a quick ratio of 0.70. According to the stock market information, the enterprise value for the company is $244.83B, which is based on a 36.09 price-to-earnings ratio, a 2.65 price-to-earnings-growth ratio, and a beta of 0.50. The fifty day moving average price for AZN is $70.47 and a two-hundred day moving average price translates $68.76 for the stock.
The latest earnings results from AstraZeneca PLC (NASDAQ: AZN) was released for Jun, 2023. According to the Drug Manufacturers – General Company, earnings per share came in at $1.08, beating analysts’ expectations of $0.95 by 0.13. This compares to $0.12 EPS in the same period last year. The net profit margin was 13.90% and return on equity was 17.00% for AZN. The company reported revenue of $11.42 billion for the quarter, compared to $10.77 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.99 percent. For the current quarter, analysts expect AZN to generate $11.68B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 09/11/2023. Investors who held shares on 08/11/2023 were paid a $0.465 dividend. On an annualized basis, this represents a $1.45 dividend and a 2.03% percent yield. There was an ex-dividend date of 08/10/2023 for this dividend. In terms of dividend payout ratio, AZN is presently at 49.50%.
